Diabetes Board decisions

The Board granted service connection for diabetes mellitus type II, related to in-service toxic exposure, effective August 10, 2022.

The appeal is remanded to obtain a TERA memorandum and medical opinions addressing the Veteran's claimed conditions, including diabetes mellitus, renal failure, peripheral neuropathy of both lower extremities, and an acquired psychiatric disorder, in relation to his service and exposure to toxic substances.

The Board denied service connection for diabetes mellitus, type 2 and bilateral upper extremity peripheral neuropathy as the evidence did not support a finding that these conditions were related to the Veteran's active duty.

The Board denied service connection for Parkinson's disease and diabetes mellitus, as there was no evidence that these conditions began during a qualifying period of active duty. The claims for rheumatoid arthritis, bladder prolapse, bronchitis, and bilateral foot disability were remanded for further development.

The Board granted service connection for diabetes mellitus, type II, finding that it is proximately due to the Veteran's service-connected PTSD.

The Board granted service connection for tinnitus and denied service connection for posttraumatic stress disorder (PTSD), pes planus, and diabetes mellitus II.

The appeal for service connection for OSA and DM II was dismissed, as the finding of a difference of opinion related to these issues provided in the January 18, 2023, rating decision was not an adverse action. The effective date for the grant of service connection for unspecified anxiety disorder could not be earlier than July 27, 2021, and a compensable disability rating for tinea pedis was denied.

The Board granted an effective date of February 7, 2013, for the award of service connection for type II diabetes mellitus based on new and material evidence received after a final disallowance.

The Board granted separate disability ratings of 20 percent for right and left lower extremity diabetic peripheral neuropathy, a 10 percent rating for the service-connected left upper extremity peripheral neuropathy, and a 30 percent rating for the respiratory disability. The initial disability rating in excess of 20 percent for diabetes mellitus was denied.

The Board denied a rating in excess of 20 percent for diabetes mellitus type II with bilateral preoperative cataracts, erectile dysfunction, and dermatophytosis.

The Board granted an earlier effective date of October 21, 2020, for the grant of service connection for diabetes mellitus, type II due to herbicide exposure under the PACT Act.

The Board denied service connection for a vision disability, to include diabetic retinopathy, cataracts, open angle glaucoma, blepharitis, left eye optic neuritis, and hypertensive retinopathy, as secondary to the Veteran's service-connected diabetes mellitus.

The Board granted service connection for diabetes, OSDD, and bilateral lower extremity peripheral neuropathy associated with diabetes. The claim for meningitis was denied.

The Board denied service connection for various conditions, including diabetes mellitus and coronary artery disease, as there was no evidence of in-service injury or disease, chronicity, or continuity of symptomatology. The Veteran's claims were also dismissed due to withdrawal at a hearing.

The Board granted service connection for diabetes mellitus, type II, and remanded the issue of whether new and material evidence has been received sufficient to reopen the claim of entitlement to service connection for bilateral hearing loss.

The Board remands the appeal for additional development, including obtaining relevant treatment records and scheduling a new examination to clarify certain testing results and distinguish between symptoms of varicose veins and diabetic PVD.

The Board denied a separate compensable rating for bilateral diabetic retinopathy and remanded the claims for service connection for skin condition, chloracne, acne, soft tissue sarcoma (basal cell carcinoma) due to herbicide exposure.

The Board granted service connection for diabetes mellitus type II, based on the Veteran's presumed exposure to herbicide agents during his service in or near the Korean Demilitarized Zone.

The Board granted readjudication of service connection for bilateral sensorineural hearing loss, diabetes mellitus type II, and obstructive sleep apnea based on new evidence.

The Board remands the claim for service connection for diabetes mellitus type II due to an inadequate VA medical opinion.